evanspharmacy.com/USA/56gb/ Listed by kairos Ransomware Group: Ransomware Claim — What’s Alleged & What To Do
Evans Pharmacy confirmed on June 17, 2025 that internal files were stolen in a ransomware attack and listed by the kairos group on evanspharmacy.com/USA/56gb/. Anyone who has records with the pharmacy should review their accounts and enable any available security alerts.
Evans Pharmacy, a United States-based pharmacy operating under evanspharmacy.com, was listed by the kairos ransomware group on June 17, 2025. Public reporting indicates that internal files totaling 56 GB were claimed as exfiltrated in a ransomware attack. The number of people affected remains unknown, and further details about the incident have not been disclosed.
This listing matters because pharmacies routinely handle sensitive personal, medical, and financial information. When a ransomware group claims to have taken internal files, individuals connected to the organization face potential risks of identity theft, fraud, or exposure of private health-related data, even if the full scope is still unconfirmed.
Breaking down the breach
According to available records, the kairos ransomware group listed Evans Pharmacy on its leak site with the entry evanspharmacy.com/USA/56gb/. The report is dated June 17, 2025. The only data description provided is that internal files were allegedly exfiltrated as part of a ransomware attack. No confirmation of encryption, ransom demands, or successful recovery has been made public. The number of individuals affected is listed as unknown, and the overall summary of the incident is recorded simply as unknown. Timing of the intrusion itself, the initial access method, and any technical indicators of compromise remain undisclosed.
Because the information originates from a threat-actor listing rather than an official organizational disclosure or independent forensic confirmation, the claim of a 56 GB data set and the characterization of the event as a ransomware attack with exfiltration should be treated as assertions by the group pending further verification.
Inside kairos
Kairos is a ransomware operation that has appeared in public threat reporting as a group that combines data encryption with data theft, a tactic commonly called double extortion. Like many such groups, kairos typically publishes victim names and claimed data volumes on dedicated leak sites to pressure organizations into paying. Public documentation of the group’s activity shows a pattern of targeting a range of mid-sized organizations across multiple sectors, often advertising the volume of stolen data in gigabytes as a measure of leverage.
In this case, the group claims to have listed Evans Pharmacy and to have obtained 56 GB of internal files. No additional statements attributed specifically to this victim—such as sample file screenshots, ransom notes, or deadlines—have been included in the available facts. Established knowledge of kairos’s methods does not extend to inventing details about how the group entered Evans Pharmacy’s systems or what negotiations, if any, followed the listing.
Who is Evans Pharmacy?
Evans Pharmacy is a pharmacy business based in the United States. Pharmacies of this type dispense prescription medications, maintain patient records, process insurance claims, and often manage inventory, supplier contracts, and employee information. They operate under strict regulatory frameworks that govern the handling of protected health information and controlled substances.
A breach involving a pharmacy is consequential because the organization sits at the intersection of healthcare delivery and personal data. Even limited exposure of internal files can affect patients who rely on the pharmacy for ongoing prescriptions, employees whose payroll or personnel records may be stored on the same systems, and business partners whose contractual or financial details appear in internal documents. The exact operational scale of Evans Pharmacy is not detailed in the public breach record, but the sector itself is known for holding data that, if compromised, can have lasting personal and clinical implications.
What data was at risk
The facts state that internal files were exfiltrated in a ransomware attack and that the volume claimed is 56 GB. No further breakdown of file types, databases, or specific categories of personal information has been disclosed. Exact contents therefore remain unconfirmed.
Organizations in the pharmacy sector typically maintain patient names, addresses, dates of birth, prescription histories, insurance identifiers, payment card or billing information, and employee records. They may also store supplier invoices, inventory logs, and internal correspondence. While these categories are common across the industry, it is not known whether any or all of them were present in the files the group claims to have taken. Readers should treat any assumption about specific data elements as speculative until official confirmation is provided.
What's at stake
For individuals, the primary risks are misuse of personal identifiers for fraud, targeted phishing that references real prescription or insurance details, and potential embarrassment or discrimination if health-related information becomes public. Because the number of affected people is unknown, it is impossible to quantify how many patients, employees, or contractors may be exposed.
For the organization, the stakes include regulatory scrutiny under health-privacy rules, possible notification obligations, reputational damage that can erode patient trust, and the operational cost of investigating and remediating the incident. Even if systems were restored quickly, the claimed exfiltration of internal files creates a longer-term exposure window during which stolen data could be sold, leaked, or used for further attacks. These consequences remain potential rather than proven, given the limited public detail.
Were you affected?
If you have been a patient, employee, or business contact of Evans Pharmacy, treat the situation with measured caution. Monitor bank and credit-card statements for unfamiliar charges, place fraud alerts with the major credit bureaus if you notice suspicious activity, and be skeptical of unsolicited emails or calls that reference pharmacy records or request personal verification. Change passwords on any accounts that reused credentials associated with the pharmacy, and enable multi-factor authentication wherever available.
You can also run a free exposure scan of your email address to check whether your information has already appeared in known breach data sets. Doing so provides an early indicator of whether your details have circulated more widely, independent of this specific incident. Continue to watch for any official notices from Evans Pharmacy or relevant authorities, as those remain the most reliable source of confirmation about who was affected and what steps the organization is taking.
AICompiled with AI assistance from public sources and published under our editorial standards.
How this breach connects
More recent breaches
www.nurturecare.com/USA/192GB Listed by kairos Ransomware Groupocbar.org/USA/114GB Listed by kairos Ransomware Groupwilsenergy.com/USA/77.1GB Listed by kairos Ransomware Groupsummitcollege.edu/USA/370GB Listed by kairos Ransomware GroupLatest breaches
Publicly posted by kairos — unverified claim, pending independent verification
Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.
Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.